ÂÜÀòÂÒÂ×

Michael F. MacLean is the chief financial officer (CFO) of Avidity Biosciences, which he joined prior to its IPO in June 2020. Mr. MacLean has more than 30 years of experience in financial leadership roles in the life sciences and other industries, and has been a key player in strategy and operations for high growth companies. Prior to Avidity, he served as CFO of Akcea Therapeutics, Inc., where he led the buildout of Akcea’s financial and commercial infrastructure, and was the CFO of PureTech Health, plc. Previously, he led Biogen’s worldwide finance operations. Earlier in his career, Mr. MacLean was an audit partner at KPMG and Andersen.